SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950124-07-004059
Filing Date
2007-08-08
Accepted
2007-08-08 09:00:59
Documents
4
Period of Report
2007-08-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a32783e8vk.htm 8-K 19961
2 EXHIBIT 99.1 a32783exv99w1.htm EX-99.1 62203
3 EXHIBIT 99.2 a32783exv99w2.htm EX-99.2 65680
4 GRAPHIC a32783a3278300.gif GRAPHIC 7257
  Complete submission text file 0000950124-07-004059.txt   159825
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-15803 | Film No.: 071033705
SIC: 2834 Pharmaceutical Preparations